Darryl Long’s Post

🎗️🔬 May is Cancer Research Month! 🎗️🔬 May is Cancer Research Month, a time to recognize the vital work being done to combat the devastating impact of cancer worldwide. As we celebrate the incredible strides made in cancer research, let's also remember those who continue to face the challenges of this disease. Together, we stand in solidarity with cancer survivors and honor the tireless efforts of researchers who are dedicated to saving lives every day. Join us in showing our unwavering support for pioneering cancer research and the millions of individuals affected by this disease. Together, we can make a difference. #CancerResearchMonth #CancerAwareness #SupportResearch #MedicalAdvancement Sources: [1] https://bit.ly/3vi4UhP

🎗 "Where do you see yourself in three years?" 🎗 #CCAM2023 🔬 During this year's Childhood Cancer Awareness Month, we introduced young researchers from St. Anna Children's Cancer Research Institute (CCRI). They are the bearers of hope, passionately dedicated to pediatric cancer research! 🚀 In our latest video, we pose an exciting question: Where do our young researchers see themselves in three years? We're eager to hear about their dreams and goals for the future! Learn more about their inspiring stories and the vital work they do. Together, we can make a difference and fight childhood cancer! 💪💛 #ChildhoodCancerResearch

Always, #RWB stands alongside our Partner, Stuart Weissman, who is currently battling esophageal cancer. We ask that you join us in supporting him and others who are going through this difficult time by sending positive thoughts and prayers, in addition to aiding esophageal cancer research. Every step taken toward raising awareness and funding research brings us closer to finding effective treatments and, ultimately, a cure. Learn more about the importance of supporting esophageal cancer research and how you can contribute to this vital cause by visiting https://ecan.org/ As University of Michigan fans, we say - #GoBlueGoStu

IARC has released the fifth IARC Evidence Summary Brief, titled “Maternal Orphans due to #Cancer: The intergenerational impact of cancer deaths in women”. This new report summarizes findings by IARC and partners on the intergenerational impact of cancer deaths in #women, highlights the scale of maternal orphans due to cancer, and calls for support to address the needs of affected children. https://lnkd.in/d32HTKA7 #InternationalWomensDay

😃Thank you to all 60+ participants in today’s STRONG AYA stakeholder forum! Such occasions are vital to unite 🇪🇺-funded projects and other cancer experts🤝 Adolescents and Young Adults (AYA) with cancer face age-specific issues that this EU-funded project seeks to address. 👀The summary report will be published soon. #CancerResearch #CancerData #YoungEuropeans | European Network of Youth Cancer Survivors | The Netherlands Cancer Institute | Fondazione IRCCS Istituto Nazionale dei Tumori di Milano

✨ V3 E3 Spotlight ✨ Cancer is a scary and uncertain disease that impacts many humans around the world. Join Rahma as she outlines several hallmarks of cancer established through years of significant research. These principles are known as the hallmarks of cancer, that help us better understand how this disease develops and persists. 🧠 Read the article here!: https://lnkd.in/g6r9XW54

Discover how early detection of cervical cancer can greatly improve survival rates for women under 65. Gain valuable insights into this topic from Julianne Cooley, a fellow member of NAACCR, in a recent study published in the American Association for Cancer Research Journal. Stay up-to-date on more of the latest news and research exploring the complexities of cancer through Surveillance posts by Narrative. You can even contribute your own post. With rigorous monitoring and comprehensive analysis of cancer data, we have the power to uncover vital information that has the potential to save lives. Find out more about cervical cancer detection and join the conversation at https://buff.ly/40ENObW. #cervicalcancer #NAACCR #NAACCRnarrative #cancerdata

#TodayisWorldCancerDay - 4 February In the UK, nearly 1 in 2 people will get cancer in their lifetime. Today is World Cancer Day - a global day to raise awareness and take action against cancer 🌍 Whatever your cancer experience, or however you've supported our work in the past, #sharethispost and help us get the word out. Cancer Research UK (CRUK) #WorldCancerDay #WCD2024

64.000 European citizens alone are diagnosed with a brain tumour annually with a median survival of less than 2 years due to the lack of targeted immunotherapy applications. Despite intensive research, the incidence and mortality rates did not change over the past 30 years. Today is the #Glioblastoma Awareness Day (GBM-day), a day devoted to increasing public awareness of glioblastoma, the most recurrent and aggressive form of brain cancer. For this occasion, I’d like to take the opportunity to share one of the projects I have been working on: GLIOMATCH is a #HorizonEurope R&I project with the ambition of pioneering targeted brain cancer treatment for adults and children. Since the start of this year, KU Leuven has led the GLIOMATCH consortium to develop a platform built with the help of extensive #clinicaltrials and a #DataDriven approach. The project will enable #immunology-based patient stratification by categorising individuals according to their immune system characteristics to customise treatments or interventions for more precise and effective healthcare strategies and make this technology accessible to clinicians. Key facts: · Received > €12.5 million in funding from the European Commission, SERI (CH) and UKRI (UK) · 5-year duration · A multidisciplinary consortium of 14 partners from 10 different member states (including clinical experts, medical practitioners, data scientists, health economists, and more) · 8 pro – and retrospective clinical trials. There are 3 key innovations behind the #GLIOMATCH treatment matching platform contributing to the European #MissionOnCancer and #EUCancerPlan: 🔬 An MRI Radio-Multiomics Digital Hub serving as a centralised platform for clinicians across Europe to upload diagnostic and follow-up #MRI scans of malignant brain tumour patients to get state-of-the-art insights into patient stratification, guidance towards personalised treatment, early detection of treatment efficacy/adverse effects, and longitudinal follow-up. 🧬A state-of-the-art spatio-temporal pathological model, to match eligible GBM/pHGG patients with the most suitable immunotherapeutic treatment schemes. This will be achieved using cutting-edge methods such as #deepimmunophenotyping, non-invasive radiological imaging, and extensive clinical #datamining of immuno-oncology-treated patient cohorts. 💾 An extensive, UNCAN.eu-compatible data lake able to incrementally add new data to enhance our understanding of why some patients respond to specific treatments while others do not. I am very happy to have helped make this project come to life and in this way make an àctual difference. Shinjini Mukherjee and I will be leading the innovation management in the future, exciting! Thanks to all the consortium members for the seamless collaboration so far and a special thanks and congratulations to Prof. Frederik De Smet for this wonderful initiative and for leading this complex project! #PrecisiOnoncology #PrecisionMedicine #DataScience

Raising awareness about #glioblastoma, an aggressive type of brain tumour affecting about 64,000 people across Europe every year, is crucial for both patients and carers. This means advocating for better research, policies, and access to advanced diagnostics and treatments for cancer patients, regardless of where they live in Europe. 📢 Addressing the persisting cancer care inequities starts with us though! Stand with us and help make the eradication of health inequities a priority in the EU! #GBMDay #BrainCancerResearch #BrainCancerAwareness